A recent study from the UW Carbone Cancer Center highlights a new method for screening cancer drugs with no risk to the patient.
Scientists at UW-Madison created a three-dimensional model using real tissues from a patient to grow blood vessels on a specialized structure. They used both normal and cancerous tissues, in order to replicate the environment within the target patient’s body.
With their reactive model, the researchers were able to test drugs used to treat the most common type of kidney cancer: renal cell carcinoma. According to a release from UW-Madison, this cancer is resistant to chemotherapy, so it’s normally treated with drugs that cut off the blood supply tumors need to grow. That growth process is referred to as angiogenesis.